Joanne Silberner

In his new book, 97-year-old Robert Jay Lifton shares the "survivor wisdom" he's learned from those who've lived through terrible events — the Holocaust, Hiroshima, POW camps.

The COVID emergency brought widespread cancellations for short-term fly-ins to run clinics. Are the missions — praised for the help they provide and criticized for a colonialist mindset — coming back?

Calliope Holingue researches how the microbiome and mind affect each other. She's part of a growing field, exploring how that connection could ultimately improve treatments for mental conditions.

Genetic analyses back up what Swahili oral tradition has long held about ancestry of people from eastern Africa — that their ancestors are from Africa and abroad.

They were pioneers in their fields, working to improve the health and lives of other women and paving the way for other female scientists.

A new report confirms a deep decrease in the world's childhood death rate. But it takes note of what the authors call an "astronomically high" rate of death after hospitalization.

The World Health Organization has created a Hub for Pandemic and Epidemic Intelligence. Dr. Chikwe Ihekweazu, who heads the group, talks about the challenges that lie ahead.

A new report from the World Health Organization contains some encouraging numbers but also cause for concern, with both cases and deaths on the upswing last year. The pandemic is just one reason.

Globally, boys and young men made up two-thirds of all deaths among young people in 2019. A recent report finds that many such deaths in this "neglected" age group are preventable.

For decades, Western docs and nurses have parachuted into poor countries to perform surgeries. That's not working in this pandemic. But there's a new twist that holds promise.

Health officials are investigating reports of mostly mild, temporary and treatable heart inflammation that may or may not be causally linked to vaccination with an mRNA vaccine against COVID-19.

When a new drug is up for FDA approval, trials may be held not only in the U.S. but other countries too. A study looks at global availability after approval. Big Pharma disagrees with the findings.

COVID-19 has renewed interest in a key way humans perceive the world. A reporter who hasn't been able to tell the scent of a rose from a sweaty gym shoe for decades takes heart in the latest science.

That's the perspective in new papers in Lancet Global Health that assess the nearly a quarter of a million studies on treatments for COVID-19.

The spread of new strains raises new questions as two COVID-19 vaccines continue their rollout across the U.S. and another vaccine candidate preps for regulatory review. Here's what you need to know.

It takes time after vaccination for immunity to the virus to build up, and no vaccine is 100% effective. Plus, scientists don't yet know if the vaccine stops viral spread. Here's what's known so far.

Within hours, U.S. states are expected have in hand their first shipments of Pfizer's newly FDA-authorized COVID-19 vaccine. It marks a new phase in the pandemic, but what's that mean for you?

When the pandemic hit, mental health professionals predicted lockdowns and social distancing would result in a wave of loneliness. But researchers who study loneliness say that hasn't happened.

Though anxiety has increased in the U.S. in recent months, a drastic spike in loneliness that psychologists expected hasn't emerged. People seem to be finding new ways to connect, researchers say.

An unprecedented five-year study aimed to find out whether the treatments to stop the spread of HIV in the West would work in sub-Saharan Africa.